GlassScriptPhysician profile
Kimberly Sweet
NPI 1922008184
$5,028.85
in general payments reported to CMS, 2019-2025
8 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.50 · 2022: $88.26 · 2023: $406 · 2024: $4,020 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,709 · Food and Beverage: $2,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,708.52 |
| Food and Beverage | $2,161.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,149.02 | 2024-2025 | Indigo System |
| Inari Medical, INC. | $1,086.17 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bolton Medical INC | $382.37 | 2023-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Silk Road Medical, INC. | $182.08 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $104.43 | 2023 | Hawkone |
| Smith+Nephew, INC. | $70.50 | 2021 | |
| Boston Scientific Corporation | $32.61 | 2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $21.67 | 2023 | Bexsero |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Sweet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.